Skip to content
AwardedPRTGoods

Aquisição do medicamento Brexucabtagene autoleucel

Published
Published 8 April 2026

Overview

Aquisição do medicamento Brexucabtagene autoleucel

Key details

Country
PRT
Status
Awarded
Category
Goods
Procedure
Direct
Published
8 April 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€1,632,504
Award date
19 February 2026
Winner
  • Gilead Sciences, Lda

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    8 April 2026

Contracting authority

  • Instituto Português de Oncologia do Porto Francisco Gentil, EPE

    Procuring entity

    Porto, PRT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Aquisição do medicamento Brexucabtagene autoleucel — won by Gilead Sciences, Lda — Skim